Top Searches
- • More Trains, Fewer Cars: Delhi Metro Adds 24 Extra Trips From May 18 To Win Back The Streets 16 minutes ago
- • India’s Cosmic First: Kuljeet Kaur Marhas Joins Elite Meteoritical Society Fellowship 1 hour ago
- • Delhi’s Rs 10 Crore Boost: Collateral-Free Loans To Power Women-Led Startups 1 hour ago
- • MTV Splitsvilla X6 Finale: Gullu And Kaira Win Trophy And Rs 20 Lakh 2 hours ago
- • When Bharat Took The Last Bite: India Officially Becomes KitKat’s Largest Playground 2 hours ago
- • WOW STORY OF THE DAY She Invested in 87 Startups on Shark Tank. Then She Became a Founder Herself and Built Arth. 1 hour ago
- • Smart Track, Safer Roads Advanced Ai Rto Office To Transform Driving Tests In Ahmedabad 3 hours ago
- • Heat Index Of A Country India Wakes Up To A Split Screen Of Heatwaves And Storm Clouds 3 hours ago
Loading market data...
Latest Top News
Show more
WOW STORY OF THE DAY She Invested in 87 Startups on Shark Tank. Then She Became a Founder Herself and Built Arth.
Pearl Doshi
May 17, 2026
330 Views
Namita Thapar, Chartered Accountant, Duke University MBA, Executive Director of Emcure Pharmaceuticals, and Shark Tank India judge, launched Arth by Emcure in 2025 as India's most science-backed D2C wellness brand. Backed by Emcure's 44-year pharmaceutical legacy and presence in 70-plus countries, with MS Dhoni and Vidya Balan as ambassadors, Arth is rewriting how India talks about women's health
A Pharmaceutical Legacy, a Shark's Insight, and a Personal Mission
- Namita Thapar completed her Chartered Accountancy from the Institute of Chartered Accountants of India and then earned her MBA from Duke University's Fuqua School of Business in the United States before returning to India to join Emcure Pharmaceuticals, the company her father Satish Mehta had built into one of India's most respected pharmaceutical organisations. She rose to become the Executive Director and Whole-Time Director, heading Emcure's India business, its largest revenue-generating unit.
- Emcure Pharmaceuticals is a publicly listed company on Indian stock exchanges, marketing pharmaceutical products across 70-plus countries with a strong presence in India, Europe, and Canada. Its therapeutic strongholds include gynaecology, cardiovascular, blood-related conditions, pain and analgesics, and oncology, making women's health already a foundational pillar of the parent organisation's identity.
- Namita's years on Shark Tank India across multiple seasons, with 87 startup investments, gave her something few pharmaceutical executives ever develop: a direct, unfiltered view of what Indian consumers actually wanted from health and wellness brands. She watched founders pitch products in categories that legacy pharma had never properly served. She saw the gap between what Emcure's R&D capabilities could produce and what Indian women were actually receiving in the market.
- The founding insight was personal and universal simultaneously. Women in India, regardless of income, education, or professional success, consistently placed their own health last. Menopause was spoken about in whispers. Intimate care was treated as taboo. Sleep disorders, brain fog, bone health, and iron deficiency were accepted as inevitable rather than addressable.
- In 2025, she launched Arth by Emcure. Arth means meaning and purpose in Sanskrit. The brand was built to help India live an arthful life.
44 Years of Science, D2C Speed, and a Founder Who Learnt Meta Marketing From Her Own Investees
- The boldest decision Namita made was to build Arth as a D2C brand rather than a prescription or OTC pharmaceutical extension. That single choice changed everything about how Arth could communicate, who it could reach, and how fast it could move.
- What makes this founding story genuinely extraordinary is Namita's willingness to learn as a first-time founder. She publicly credited the founders of Arata, a Shark Tank Season 3 investee, for mentoring her in performance marketing and meta marketing as she built Arth. A seasoned executive with a ₹600 crore estimated net worth and 87 startup investments behind her, going back to her own portfolio companies to learn from them, is the kind of founder humility that produces genuinely great brands.
- Every Arth product is personally curated by Namita in consultation with top medical experts, clinically validated by Emcure's R&D team, and formulated using ingredients backed by clinical studies for both safety and efficacy. Ancient Indian herbs like Brahmi are combined with modern science. Bitter drops sourced after Namita personally researched the science with doctors at Germany's Lanserhof spa were introduced to India as a product for bloating and cravings. The brand explicitly commits to ethical marketing, openly communicating that supplements support rather than substitute a good diet and lifestyle.
- The Arth Travels marketing series became a hit, with Namita documenting her global travels alongside Arth products, raw and real, showing the brand as a lifestyle companion rather than a pharmaceutical supplement. The Uncondition Yourself wellness talk show, hosted by Namita herself with top doctors, runs as an education platform that destigmatises women's health topics through open conversation.
- Two of India's most strategically chosen brand ambassadors anchor Arth's credibility. MS Dhoni joined as the first ambassador, his values of integrity and excellence reflecting the brand's standards and drawing attention to how often women's health issues go unnoticed in families. Vidya Balan, announced in March 2025, spotlights three key products including Intimate Care, Sleep Support Gummies, and Brain Fog Aid, reinforcing Arth's commitment to the health conversations most brands still approach with discomfort.
Scale and Real-World Impact
- Arth by Emcure was launched in 2025 and is available on arthbyemcure.com, all major e-commerce platforms, Reliance retail stores, Apollo Pharmacy, and quick commerce platforms. Parent company Emcure Pharmaceuticals is publicly listed on Indian stock exchanges, operates across 70-plus countries, and has 44 years of pharmaceutical R&D behind it. Namita Thapar holds a 3.5% stake in Emcure with a potential return of ₹12,700 crore post-IPO and has an estimated net worth of ₹600 crore as of 2025. India's nutraceuticals and wellness supplements market is projected to reach $18 billion by 2025, growing at 12 to 15 percent annually. Arth is Emcure's first consumer-facing D2C wellness brand, representing a strategic diversification from prescription pharmaceuticals into the lifestyle wellness space. The product range spans sleep support gummies, iron gummies, intimate care, brain fog aid, perimenopause support, bone health formulations, and bitter drops, with new products added through ongoing personal research by Namita.
The Best Founders Know What They Know and Are Humble About What They Are Still Learning
- The sharpest lesson from Arth's journey is one that no business school teaches as directly as Namita Thapar is living it: the skills that made you exceptional in one role are a foundation, not a finish line, when you become a founder.
- Namita had 44 years of pharmaceutical legacy behind her. She had 87 startup investments, a Duke MBA, and a national platform. And she still went back to the founders she had invested in and asked them to teach her performance marketing.
- That combination, deep domain credibility and genuine beginner's humility, is what builds brands that earn trust rather than simply buy it.
- "Arth stands for trust. It stands for education. We stand for ethical marketing and honestly communicate that supplements support and do not substitute a good diet, exercise routine, and mindful lifestyle," Namita says.
- She spent years evaluating founders. She became one herself. And in doing so, she brought India's most credible pharmaceutical legacy directly into the living rooms, medicine cabinets, and daily wellness routines of the people who needed it most.
Sources: StartupPedia, Snackfax, Passionate In Marketing, Arth Official Website, Planify, Emcure Official / Crunchbase, LinkedIn
Stay Ahead – Explore Now! Stained Five Minutes Before Leaving The House? Here Is What Actually Works






